Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Liberalized Diets During Neutropenia: Ongoing Uncertainty in Hematopoietic Stem-Cell Transplantation.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 01, 2026
Factors Associated with Increased Healthcare Utilization Within 30 and 90 Days Post-Discharge of CAR-T Cell Therapy in Patients with R/R LBCL.
Journal: Hematology reports
Published: April 23, 2026
Hematopoietic Cell Transplantation, Version 3.2025, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: October 09, 2025
A phase 1 trial of ibrutinib and azacitidine for higher risk myelodysplastic syndromes (University of California Hematologic Malignancies Consortium Study 1503).
Journal: Leukemia research
Published: March 18, 2025
A prospective clinical trial of GVHD prophylaxis with posttransplant cyclophosphamide and abatacept.
A prospective clinical trial of GVHD prophylaxis with posttransplant cyclophosphamide and abatacept.
Journal: Blood advances
Published: October 17, 2024
A Difficult Case of Calcineurin Inhibitor Neurotoxicity Post-Haploidentical HCT With a Successful Novel Solution: Cytotoxic T-Lymphocyte-Associated Protein 4-Immunoglobulin Blockade for GVHD Prophylaxis.
Journal: Cell transplantation
Published: July 30, 2024
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults.
Journal: The New England journal of medicine
Published: July 24, 2024
Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3.
Journal: Leukemia
Published: July 19, 2024
Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids.
Journal: Bone marrow transplantation
Published: August 18, 2023
Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Large B-Cell Lymphoma (LBCL): A Single-Institution Experience.
Journal: Cancers
Published: July 08, 2023
Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3.
Journal: Journal for immunotherapy of cancer
Published: June 18, 2023
Last Updated: 09/26/2026